000 | 01959 a2200553 4500 | ||
---|---|---|---|
005 | 20250517100247.0 | ||
264 | 0 | _c20170505 | |
008 | 201705s 0 0 eng d | ||
022 | _a1090-2430 | ||
024 | 7 |
_a10.1016/j.expneurol.2016.05.025 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aBeamer, Matthew | |
245 | 0 | 0 |
_aPrimary blast injury causes cognitive impairments and hippocampal circuit alterations. _h[electronic resource] |
260 |
_bExperimental neurology _c09 2016 |
||
300 |
_a16-28 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, U.S. Gov't, Non-P.H.S. | ||
650 | 0 | 4 |
_a6-Cyano-7-nitroquinoxaline-2,3-dione _xpharmacology |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 | _aBiomechanical Phenomena |
650 | 0 | 4 |
_aBrain Injuries _xcomplications |
650 | 0 | 4 |
_aCalcium-Binding Proteins _xmetabolism |
650 | 0 | 4 |
_aCognition Disorders _xetiology |
650 | 0 | 4 | _aDisease Models, Animal |
650 | 0 | 4 |
_aExcitatory Amino Acid Antagonists _xpharmacology |
650 | 0 | 4 |
_aExploratory Behavior _xphysiology |
650 | 0 | 4 |
_aFear _xpsychology |
650 | 0 | 4 |
_aGlial Fibrillary Acidic Protein _xmetabolism |
650 | 0 | 4 |
_aHippocampus _xpathology |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMaze Learning |
650 | 0 | 4 |
_aMembrane Potentials _xdrug effects |
650 | 0 | 4 | _aMice |
650 | 0 | 4 | _aMice, Inbred C57BL |
650 | 0 | 4 |
_aMicrofilament Proteins _xmetabolism |
650 | 0 | 4 |
_aMotor Activity _xphysiology |
650 | 0 | 4 |
_aNerve Net _xpathology |
650 | 0 | 4 | _aRotarod Performance Test |
650 | 0 | 4 | _aTime Factors |
700 | 1 | _aTummala, Shanti R | |
700 | 1 | _aGullotti, David | |
700 | 1 | _aKopil, Catherine | |
700 | 1 | _aGorka, Samuel | |
700 | 1 | _aBass, Cameron R Dale | |
700 | 1 | _aMorrison, Barclay | |
700 | 1 | _aCohen, Akiva S | |
700 | 1 | _aMeaney, David F | |
773 | 0 |
_tExperimental neurology _gvol. 283 _gno. Pt A _gp. 16-28 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.expneurol.2016.05.025 _zAvailable from publisher's website |
999 |
_c26078370 _d26078370 |